Eurobio Scientific Société anonyme (EPA: ALERS)
24.65
+0.05 (0.20%)
Aug 30, 2024, 5:39 PM CET
ALERS Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 203.56 | 203.56 | 190.96 | 162.47 | 126.73 | 110.72 | Upgrade
|
Other Revenue | 3 | 3 | 3.34 | 3.92 | 2.78 | 1.94 | Upgrade
|
Revenue | 206.55 | 206.55 | 194.29 | 166.39 | 129.51 | 112.65 | Upgrade
|
Revenue Growth (YoY) | 6.31% | 6.31% | 16.77% | 28.48% | 14.96% | 10.67% | Upgrade
|
Cost of Revenue | 78.45 | 78.45 | 73.87 | 60.41 | 50.46 | 44.29 | Upgrade
|
Gross Profit | 128.11 | 128.11 | 120.42 | 105.98 | 79.04 | 68.36 | Upgrade
|
Selling, General & Admin | 92.72 | 92.72 | 88.28 | 72.77 | 54.18 | 46.24 | Upgrade
|
Other Operating Expenses | 1.32 | 1.32 | 1.49 | 1.42 | 1.37 | 1.71 | Upgrade
|
Operating Expenses | 109.71 | 109.71 | 104.07 | 86.22 | 64.93 | 56.14 | Upgrade
|
Operating Income | 18.4 | 18.4 | 16.36 | 19.76 | 14.11 | 12.23 | Upgrade
|
Interest Expense | -4.19 | -4.19 | -3.34 | -2.26 | -1.39 | -0.72 | Upgrade
|
Interest & Investment Income | 1.09 | 1.09 | 0.13 | - | 0.02 | 0.03 | Upgrade
|
Currency Exchange Gain (Loss) | -1.17 | -1.17 | 0.76 | 0.92 | 0.13 | -0 | Upgrade
|
Other Non Operating Income (Expenses) | -0.36 | -0.36 | -0.35 | -0.18 | -0.22 | 0.01 | Upgrade
|
EBT Excluding Unusual Items | 13.78 | 13.78 | 13.55 | 18.25 | 12.67 | 11.54 | Upgrade
|
Merger & Restructuring Charges | -1.99 | -1.99 | -2.97 | -0.53 | -1.38 | -0.78 | Upgrade
|
Impairment of Goodwill | - | - | - | - | 0.06 | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.74 | -0.74 | 3.89 | -0.01 | -0.18 | -0.17 | Upgrade
|
Asset Writedown | 0.03 | 0.03 | - | - | - | - | Upgrade
|
Other Unusual Items | -3.61 | -3.61 | -0.04 | -0.11 | -3.98 | -0.01 | Upgrade
|
Pretax Income | 7.45 | 7.45 | 14.44 | 17.6 | 7.19 | 10.58 | Upgrade
|
Income Tax Expense | 0.33 | 0.33 | 3.08 | 3.75 | 1.55 | 1.76 | Upgrade
|
Earnings From Continuing Operations | - | 7.13 | 11.35 | 13.86 | 5.64 | 8.82 | Upgrade
|
Net Income to Company | - | 7.13 | 11.35 | 13.86 | 5.64 | 8.82 | Upgrade
|
Net Income | 7.13 | 7.13 | 11.35 | 13.86 | 5.64 | 8.82 | Upgrade
|
Net Income to Common | 7.13 | 7.13 | 11.35 | 13.86 | 5.64 | 8.82 | Upgrade
|
Net Income Growth | -37.23% | -37.23% | -18.08% | 145.80% | -36.08% | 9.23% | Upgrade
|
Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 19 | 17 | Upgrade
|
Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 19 | 17 | Upgrade
|
Shares Change (YoY) | 0.06% | 0.06% | -0.41% | 18.93% | 10.80% | 7.13% | Upgrade
|
EPS (Basic) | 0.32 | 0.32 | 0.51 | 0.62 | 0.30 | 0.52 | Upgrade
|
EPS (Diluted) | 0.32 | 0.32 | 0.51 | 0.62 | 0.30 | 0.52 | Upgrade
|
EPS Growth | -37.27% | -37.27% | -17.74% | 106.67% | -42.31% | 1.96% | Upgrade
|
Free Cash Flow | -4.89 | -4.89 | -28.02 | 6.47 | 0.75 | 8.19 | Upgrade
|
Free Cash Flow Per Share | -0.22 | -0.22 | -1.26 | 0.29 | 0.04 | 0.48 | Upgrade
|
Gross Margin | 62.02% | 62.02% | 61.98% | 63.70% | 61.03% | 60.68% | Upgrade
|
Operating Margin | 8.91% | 8.91% | 8.42% | 11.88% | 10.90% | 10.85% | Upgrade
|
Profit Margin | 3.45% | 3.45% | 5.84% | 8.33% | 4.35% | 7.83% | Upgrade
|
Free Cash Flow Margin | -2.37% | -2.37% | -14.42% | 3.89% | 0.58% | 7.27% | Upgrade
|
EBITDA | 23.99 | 23.99 | 30.66 | 31.8 | 23.5 | 20.42 | Upgrade
|
EBITDA Margin | 11.61% | 11.61% | 15.78% | 19.11% | 18.14% | 18.12% | Upgrade
|
D&A For EBITDA | 5.59 | 5.59 | 14.31 | 12.03 | 9.38 | 8.19 | Upgrade
|
EBIT | 18.4 | 18.4 | 16.36 | 19.76 | 14.11 | 12.23 | Upgrade
|
EBIT Margin | 8.91% | 8.91% | 8.42% | 11.88% | 10.90% | 10.85% | Upgrade
|
Effective Tax Rate | 4.39% | 4.39% | 21.36% | 21.27% | 21.60% | 16.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.